Results 201 to 210 of about 23,750 (257)

The Disruption of the HIV-1 Gag Start Codon via Editing Using MmCas12m-Dual Base Editor-Loaded Virus-like Particles. [PDF]

Curr Issues Mol Biol
Aliev T, Imatdinov A, Prudnikova E, Taranov O, Emtsova K, Imatdinov I, Agafonov A.   +6 more
europepmc   +1 more source

VLP-based indirect ELISA enables reliable sero-diagnosis and epidemiological monitoring of duck circovirus. [PDF]

Front Vet Sci
Qiu S, Guo F, Zhao L, Zhong Z, Wang Y.
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source

Co-release of tick-borne encephalitis virus RNA and structural proteins via virus-like particles and extracellular vesicles. [PDF]

J Gen Virol
Křížová I, Klimešová A, Dostálková A, Racková J, Kaufmanová J, Novotný R, Danda M, Matošević I, Franta Z, Tykalová H, Grubhoffer L, Rumlová M.   +11 more
europepmc   +1 more source

Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. [PDF]

Nat Commun
Yman V, Rosado J, Ochida N, Garcia L, Gasasira MF, Baudemont G, Cramer E, Dupont-Rouzeyrol M, Huet K, Douine M, Sanna A, Lambert Y, Carrasco-Escobar G, Nolasco O, Gamboa D, Fall G, Ndiaye O, Faye O, Loucoubar C, Toure-Balde A, Niang M, Vigan-Womas I, Cauchemez S, White MT.   +23 more
europepmc   +1 more source

DNA origami-based virus-like particles: a new class of HIV vaccine candidates with superior immunogenic properties. [PDF]

Signal Transduct Target Ther
Muecksch F, Hamdan J, Fackler OT.
europepmc   +1 more source

A cluster of acidic residues in the cytoplasmic domain of SARS-CoV-2 Spike is required for virion-incorporation and infectivity. [PDF]

PLoS One
Stoneham CA, Singh R, De Leon A, Tafelmeyer P, Acosta F, Fuori A, Anderson M, Ramirez PW, Schwartzer-Sperber HS, Pillai S, Lewinski MK, Guatelli J.   +11 more
europepmc   +1 more source

Tremor pathophysiology. [PDF]

Clin Park Relat Disord
Elble RJ.
europepmc   +1 more source

Molecular characterization of rabbit hemorrhagic disease virus type 2 and long-lasting protection conferred by a VLP-based vaccine. [PDF]

BMC Vet Res
Wang Y, Qiao P, Wu H, Tong X, Wang T, Wang L, Yang Y, Su X, Liu C, Chen Y, Wang L, Wang M, Xi X, Wang F, Pang W, Liu Y, Tian K.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Production and purification of hybrid Ty-VLPs

Molecular Biotechnology, 1994
This article describes how pure Ty-VLPs (virus-like particles) can be prepared from hybrid Ty-VLPs. Many different hybrid Ty-VLPs have been produced and may be easily purified. Since the sedimentation properties of different hybrid Ty-VLPs are similar, a simple purification process can be used for any VLP.
N R, Burns, J E, Gilmour, S M, Kingsman, A J, Kingsman, S E, Adams   +4 more
openaire   +3 more sources